Introduction {#S1}
============

Climate change and global warming have increased the toll of mosquito-borne diseases, due to development of favorable meteorological conditions for mosquito breeding^[@R1]^. Similar to other mosquito-borne flaviviruses such as Dengue virus, ZIKV is also transmitted by *Aedes* mosquitoes that are widely spread in most parts of the world^[@R2]^. Currently, ZIKV outbreaks have been reported in 59 countries, mainly affecting the North and South America continents^[@R3]^. Despite mild symptomatic illness being exhibited by only 20% of infected individuals, ZIKV has been unexpectedly associated with almost 3,000 cases of microcephaly and/or central nervous system malformations reported in 29 countries^[@R3]^. When ZIKV re-emerged on Yap Island in 2007, it appeared to have evolved from the original African lineage first discovered back in 1947 in Uganda, taking a new form, now identified as the Asian lineage^[@R4],[@R5]^. Despite a 90% sequence homology between the two lineages, stark differences in the replication kinetics, infectivity and immune responses have been reported during infection of neural cells^[@R6]^. Recent advances on ZIKV have shed insights on its tropism for the maternal-fetal interface. ZIKV has been detected in placental tissues of infected expectant mothers, specifically within the placental macrophages, known as Hofbauer cells and intervillous histiocytes found on the maternal side^[@R7],[@R8]^. Additionally, the neurotropism of ZIKV for glial cells and endothelial cells of fetal brains has also been identified^[@R8]^.

Pregnancy is a sophisticated immune-altering process which requires prudent immunomodulation of innate immunity to ensure healthy pregnancy outcomes^[@R9]^. In particular, circulating maternal monocytes play a crucial role, where the activation and transition of monocytes to macrophages is essential for healthy placental development^[@R10],[@R11]^. Blood monocytes exhibit morphological and functional plasticity that can be categorized into: (i) classical (CD14^hi^ CD16^−^), (ii) intermediate (CD14^hi^ CD16^+^) and (iii) non-classical (CD14^lo^ CD16^+^) subsets^[@R12]^. In addition, monocytes can further differentiate into pro-inflammatory M1 or anti-inflammatory M2 macrophages^[@R11],[@R13]^. While the fate of these monocyte subsets remains a subject of debate, findings from a mouse model of vascular inflammation have suggested that classical and non-classical monocytes are most likely to differentiate into M1 and M2 macrophages, respectively^[@R14]^. During pregnancy, the continuous growth of the semi-allogeneic fetus in the expectant mother leads to an expansion of an intermediate monocyte population and a shift from T helper (Th)1 to Th2-dominating immunity in the peripheral system^[@R15]^. This alteration of immune responsiveness commences in early pregnancy when blood monocytes recruited to the placenta are converted into M2 macrophages to ensure an immunosuppressive environment for fetus development^[@R10]^. Activated monocytes are cytokine factories capable of secreting immune mediators that in turn further direct monocyte differentiation. For instance, C-X-C motif chemokine ligand (CXCL)10, interleukin (IL)-23A, IL-12, cluster of differentiation (CD)64, CD80, indoleamine 2,3-dioxygenase (IDO), suppressor of cytokine signaling 1 (SOCS1), and C-C chemokine receptor type 7 (CCR7) promote differentiation into M1 macrophages, whereas IL-10, arginase (Arg)-1, CD200R, CD163, CD23, C-C motif chemokine 22 (CCL22), vascular endothelial growth factor A (VEGFα), chitinase-3-like protein 1 (CHI3L1/YKL-40) and transforming growth factor beta (TGF-β) prime M2 macrophage polarization^[@R16]--[@R21]^. Indeed, overt activation of monocytes/macrophages can induce excessive cytokine production, leading to pregnancy complications such as pre-elampsia^[@R10],[@R22]^.

Despite the established placental tropism of ZIKV, little is known regarding the target cells in the blood and their immune responses elicited by ZIKV viremia. Here, we identified CD14^+^ monocytes as the primary target for the infection of two different lineages of ZIKV, which ultimately promoted differential monocytic shifts. Asian ZIKV infection induced the pronounced expansion of non-classical monocytes leading to M2-skewed immunosuppressive phenotype evidenced by the overt production of IL-10. In contrast, African ZIKV infection promoted inflammatory M1-skewed immune responses along with the specific induction of CXCL10 by intermediate monocytes. Furthermore, blood from pregnant women showed an enhanced infectivity to African and Asian ZIKV, leading to pronounced M1/M2-skewed immune responses. Finally, multiplex cytokine array of sera from ZIKV^+^ symptomatic pregnant women also showed increased levels of M2-skewed immunosuppressive cytokines and fibronectin-1 (FN1) associated with pregnancy complications. This study demonstrates the differential phenotypic responses of human blood monocytes induced by different lineages of ZIKV following infection and sheds important insights to the pronounced immune responses present during pregnancy.

Results {#S2}
=======

ZIKV specifically targets human CD14^+^ blood monocytes, inducing phenotypic shift {#S3}
----------------------------------------------------------------------------------

Infections of heparinized whole blood obtained from healthy donors were performed using African ZIKV (MR766) and Asian ZIKV (H/PF/2013) at multiplicity of infection (MOI) 1 ([Fig. 1a](#F1){ref-type="fig"}). At 24 hour post infection (hpi), PBMCs were isolated from whole blood specimens and the susceptibility to ZIKV infection was determined using viral load qRT-PCR and fluorescence-activated cell sorting (FACS). Interestingly, despite 90% sequence identity between ZIKV MR766 and H/PF/2013 strains, significantly higher viral burden was detected in PBMCs infected with MR766 strain than in those infected with H/PF/2013 strain ([Fig. 1b](#F1){ref-type="fig"}). To identify the primary target cells by ZIKV infection, we sorted and gated the isolated PBMCs by flow cytometry into four major blood immune subsets (monocytes, NK cells, T cells and B cells) ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}), followed by detection of the ZIKV NS1 RNA and envelope (E) protein. Viral load and FACS analyses identified CD14^+^ monocytes among these sorted immune subsets as the primary target cells for ZIKV infection ([Fig. 1c,d](#F1){ref-type="fig"}). Similarly, higher viral burdens were detected in CD14^+^ monocytes infected with the MR766 strain than in those infected with the H/PF/2013 strain ([Fig. 1c,d](#F1){ref-type="fig"}).

CD14^hi^ CD16^−^ classical monocytes are the dominant monocyte subsets in blood which rapidly undergo activation and phenotypic shift upon stimulation. To determine whether ZIKV infections drive the phenotypic shift of classical monocytes into other subsets, we examined ZIKV-infected monocytes using CD14 and CD16 surface markers ([Supplementary Fig. 1b](#SD1){ref-type="supplementary-material"}). Indeed, either MR766 or H/PF/2013 ZIKV infection induced specific expansion of CD14^lo^ CD16^+^ non-classical monocytes, but not that of CD14^hi^ CD16^+^ intermediate monocytes. Surprisingly, despite its lower virus burden, H/PF/2013-infected monocytes showed significantly higher expansion of CD14^lo^ CD16^+^ non-classical monocytes than MR766-infected monocytes ([Fig. 1e](#F1){ref-type="fig"}). These data identified CD14^+^ monocytes as the primary target cells for ZIKV infection, in which the H/PF/2013 strain drives a higher expansion of CD14^lo^ CD16^+^ non-classical monocytes despite its lower viral burden when compared to the MR766 strain.

Different lineages of ZIKV differentially affect expressions of cytokines and immune modulatory genes {#S4}
-----------------------------------------------------------------------------------------------------

Activated monocytes are key producers of cytokines in blood which subsequently influence monocyte differentiation. To determine whether ZIKV infection affects cytokine expression, PBMCs were isolated from whole blood at 24 hpi with MR766 ZIKV or H/PF/2013 ZIKV and subjected to qRT-PCR screening for 43 cytokines and immune modulatory genes commonly associated with acute viral infection, which were further categorized into four different pathways \[type I interferon (IFN)-related signaling, inflammation, M1-skewed pro-inflammation, and M2-skewed immunosuppression). Heat map representation revealed the contrasting induction pattern of cytokines and immune mediators in response to the infection with two different lineages of ZIKV strains ([Fig. 2a](#F2){ref-type="fig"}). MR766-infected whole blood exhibited an apparent increase of IFN-β in plasma, while little or no increase of IFN-β detected upon H/PF/2013 infection ([Fig. 2b](#F2){ref-type="fig"}). Consistently, MR766 infection elicited a significantly higher induction of *signal transducer and activator of transcription* (*STAT*)*1/2, 2′-5′-oligoadenylate synthetase* (*OAS*) *1/3, viperin, IFN regulatory factor (IRF)7*/*9, and nuclear factor-kappa B (NF-κB)* subunits *p50 and p65* when compared to H/PF/2013 infection ([Fig. 2c](#F2){ref-type="fig"} and [Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). Interestingly, a panel of cytokines and immune modulatory genes (*CXCL10*, *IL-23A*, *CD64*, *CD80*, *IL-18*, *IDO*, *SOCS1* and *CCR7*) associated with M1-skewed inflammation was profoundly induced specifically upon MR766 infection ([Fig. 2d,e](#F2){ref-type="fig"} and [Supplementary Fig. 2c,d](#SD1){ref-type="supplementary-material"}). By striking contrast, H/PF/2013-infected PBMCs demonstrated a significant elevation of M2-skewed immunosuppression related genes (*IL-10*, *Arg-1*, *CD200R, CD163*, *CD23*, *CCL22* and *VEGFα*) ([Fig. 2d,e](#F2){ref-type="fig"} and [Supplementary Fig. 2c,d](#SD1){ref-type="supplementary-material"}).

As CXCL10 and IL-10 cytokines are crucial for priming monocytes/macrophages into pro-inflammatory M1-skewed and immunosuppressive M2-skewed phenotypes, respectively^[@R17]^, we sorted mock- and ZIKV-infected PBMCs into monocytes, NK cells, T cells and B cells, followed by qRT-PCR analysis. These results showed the specific induction of *CXCL10* and *IL-10* expressions in ZIKV-infected CD14^+^ monocytes. Strikingly, MR766-infected monocytes exhibited a high level of *CXCL10* expression, while a high *IL-10* expression was detected in H/PF/2013-infected monocytes ([Fig. 2f](#F2){ref-type="fig"}). Consistent with these observations, ELISA performed on plasma of mock- and ZIKV-infected whole blood specimens at 24 hpi showed a considerable production of CXCL10 was detected upon MR766 infection, whereas a significant production of IL-10 was observed upon H/PF/2013 infection ([Fig. 2g](#F2){ref-type="fig"}). Together, these data indicate that different lineages of ZIKV differentially affect the expression of cytokine and immune modulatory genes associated with M1- or M2-skewed monocytes/macrophage phenotypes.

Asian ZIKV preferentially targets non-classical monocytes, driving specific IL-10 expression {#S5}
--------------------------------------------------------------------------------------------

To further address the differential expansion of monocyte subsets upon infection with different lineages of ZIKV, we infected total monocytes isolated from human whole blood with H/PF/2013 or MR766, followed by sorting into individual monocyte subsets ([Fig. 3a](#F3){ref-type="fig"}). Despite infection at the same MOI, the H/PF/2013 strain showed much lower viral loads in infected monocytes than the MR766 strain ([Fig. 3b,d](#F3){ref-type="fig"}). Since *in vitro* differentiation of monocytes to macrophages takes 3--5 days post stimulation^[@R23],[@R24]^, mock- or ZIKV-infected monocytes were harvested at 2 dpi for apparent detection of M1-/M2-skewed markers, and subsequently sorted into individual monocyte subsets. This showed that H/PF/2013 infection led to the apparent decrease of classical monocytes in conjunction with the considerable increase of non-classical monocytes ([Fig. 3c](#F3){ref-type="fig"}). Analysis of the ZIKV intracellular E protein and NS1 RNA load revealed that MR766 preferentially infects intermediate monocytes, while H/PF/2013 infects non-classical monocytes at a higher magnitude ([Fig. 3e,f](#F3){ref-type="fig"}). Furthermore, MR766-infected classical/intermediate monocytes exhibited a high level of *CXCL10* expression, while a high *IL-10* expression was detected in H/PF/2013-infected non-classical monocytes ([Fig. 3g,h](#F3){ref-type="fig"}). Finally, infection with either MR766 or H/PF/2013 did not elicit detectable cell death at 48 hpi ([Fig. 3i](#F3){ref-type="fig"}). These data further demonstrate that different lineages of ZIKV infection differentially target M1- or M2-skewed monocyte subsets.

Different immunologic traits between African and Asian lineage ZIKV strains {#S6}
---------------------------------------------------------------------------

To test that differential levels of virus infectivity, non-classical monocyte expansion and immunoregulatory gene expression were a conserved immunologic trait between African and Asian lineage ZIKV strains, whole human blood samples were infected with additional African lineage IbH30656 and Asian lineage PRVABC59 ZIKV strains at different MOIs, and PBMCs and plasma were isolated at 40 hpi. Consistent with previous results ([Fig. 1b](#F1){ref-type="fig"}), lower ZIKV burden was observed upon infection with Asian ZIKV PRVABC59 and H/PF/2013 when compared to infection with African ZIKV counterparts MR766 and IbH30656 ([Supplementary Fig. 3a,d](#SD1){ref-type="supplementary-material"}). Furthermore, the apparent expansions of CD14^lo^ CD16^+^ non-classical monocytes was observed following ZIKV PRVABC59 infection, whereas a minimal increase of CD14^lo^ CD16^+^ non-classical monocytes was observed following African ZIKV IbH30656 infection ([Supplementary Fig. 3b,e](#SD1){ref-type="supplementary-material"}). Similarly, the robust induction of *CXCL10* expression was observed upon African ZIKV IbH30656 infection, but not upon ZIKV PRVABC59 infection. In contrast, *IL-10* expression was induced only upon Asian ZIKV PRVABC59 infection ([Supplementary Fig. 3c,f](#SD1){ref-type="supplementary-material"}). Thus, these results demonstrate that lower virus burden, non-classical monocyte expansion and M2-skewed immunosuppression gene expression are commonly associated with Asian ZIKV strains, whereas higher virus burden and M1-skewed inflammatory gene expression are triggered by African ZIKV strains.

Pregnancy is associated with enhanced ZIKV infection and profound monocyte subset shift {#S7}
---------------------------------------------------------------------------------------

Despite numerous clinical cohort studies of ZIKV-infected pregnant women, the exact acute immunological effects induced by ZIKV infection remain unknown. To investigate if ZIKV differentially altered blood immunity during different trimesters of pregnancy, we infected whole blood specimens obtained from women in their first, second and third trimester of gestation. Whole blood specimens of age-matched non-pregnant women were included as controls. Higher viral burdens were detected in PBMCs isolated from first trimester pregnant women following ZIKV MR766 and H/PF/2013 infections as compared to non-pregnant women, albeit higher viral loads were detected following MR766 infection than following H/PF/2013 infection ([Fig. 4a,b](#F4){ref-type="fig"}). We further confirmed that CD14^+^ monocytes were the primary target cells for ZIKV infection during pregnancy, and that the H/PF/2013 strain showed lower viral infection in these monocytes than the MR766 strain ([Fig. 4c](#F4){ref-type="fig"}). Surprisingly, H/PF/2013 infection induced a dramatic expansion of CD14^lo^ CD16^+^ non-classical monocytes in maternal blood from the first and second trimesters of pregnancy, while blood from the third trimester of pregnancy exhibited a non-classical monocyte expansion similar to blood from non-pregnant women ([Fig. 4d,e](#F4){ref-type="fig"}). Compared to H/PF/2013 infection, small increase of non-classical monocytes was observed with MR766 infection of blood from non-pregnant and pregnant women in all trimesters of pregnancy ([Fig. 4d,e](#F4){ref-type="fig"}). These results provide the first experimental evidence that the early stage of pregnancy is a period of high susceptibility to ZIKV infection, leading to a dramatic expansion of CD14^lo^ CD16^+^ non-classical monocytes in maternal blood.

Differential expression of immune modulatory genes in the blood of pregnant women upon African or Asian lineage ZIKV infection {#S8}
------------------------------------------------------------------------------------------------------------------------------

Next, we characterized the expression profiles of IFN signaling related genes, M1-skewed inflammation genes, and M2-skewed immunosuppression genes in PBMCs isolated from blood of pregnant and non-pregnant women at 40 hpi with ZIKV ([Fig. 5a](#F5){ref-type="fig"}). MR766 infection induced IFN-β production in plasma of pregnant and non-pregnant women, albeit a significantly lower level of IFN-β production was noted in plasma of pregnant women as compared to that of non-pregnant women ([Fig 5a](#F5){ref-type="fig"}). On the other hand, H/PF/2013 infection led to lower IFN-β response in blood of both pregnant and non-pregnant women than MR766 infection ([Fig. 2b](#F2){ref-type="fig"} and [5a](#F5){ref-type="fig"}). In addition, *STAT1/2, OAS1/3* and *viperin* expression in blood of pregnant women were highly elevated following MR766 infection, but not following infection with H/PF/2013 ([Fig. 5b](#F5){ref-type="fig"}).

Pregnancy intrinsically displays a high magnitude of M2-polarized gene expression, particularly during first and second trimesters^[@R11]^. Upon mock infection condition, expression of M2-skewed immunosuppression markers (*IL-10*, *Arg-1*, *CD200R*, *YKL-40*, *CD163* and *VEGFα*) were significantly higher in the blood of pregnant women than in that of non-pregnant subjects ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). In contrast, the suppression of *CXCL10* and *IL-23A* expressions were observed in blood from pregnant subjects, while expression of other M1-related markers was unchanged regardless of pregnancy status ([Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}). Upon MR766 infection, plasma CXCL10 levels were significantly elevated in plasma of both non-pregnant and pregnant subjects, though to a lower extent in that of pregnant women ([Fig. 5c](#F5){ref-type="fig"}). Similarly, the expression of M1-skewed inflammation related genes including *CXCL10*, *IDO*, *CD80*, *CCR7*, *SOCS1*, *IL-23A*, *IL-12 p35* and *IL-18* were highly induced in MR766-infected blood from pregnant women ([Fig. 5d](#F5){ref-type="fig"} and [Supplementary Fig. 4c](#SD1){ref-type="supplementary-material"}). Despite elevated basal plasma IL-10 levels and expression of M2-related genes during pregnancy ([Fig. 5e](#F5){ref-type="fig"} and [Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}), H/PF/2013 infection further enhanced plasma IL-10 levels in plasma of pregnant women, particularly during the first and second trimesters ([Fig. 5e](#F5){ref-type="fig"}), and the *CCL22* and *YKL-40* expression in their blood ([Fig. 5f](#F5){ref-type="fig"}). In addition, expression of M2-related genes (*IL-10*, *Arg-1*, *CD200R*, *CCL22*, *YKL-40* and *CCL2*) in blood of non-pregnant women was also increased upon H/PF/2013 infection, but not following MR766 infection ([Fig. 5f](#F5){ref-type="fig"} and [Supplementary Fig. 4d](#SD1){ref-type="supplementary-material"}). Finally, multiplex cytokine array analyses of sera from 30 RT-PCR confirmed ZIKV^+^ symptomatic pregnant women and 14 healthy control pregnant women demonstrated overt expression of M2-skewed immunosuppressive cytokines IL-10, CD163 and YKL-40, but not that of M1 cytokine IL-12 p40, in sera of ZIKV^+^ infected pregnant women ([Fig. 5g--j](#F5){ref-type="fig"}). Serum IL-10 was elevated particularly in the first and second trimesters of pregnancy in ZIKV^+^ women, whereas serum CD163 and YKL-40 were significantly increased in all trimesters of pregnancy in ZIKV^+^ women ([Fig. 5g--i](#F5){ref-type="fig"}). Finally, serum IL-10, CD163 and YKL-40 were considerably high in ZIKV^+^-viremic or viruric pregnant women than in healthy control pregnant women ([Fig. 5g--i](#F5){ref-type="fig"}). Together, analyses of *in vitro* infection and that of patient specimens clearly demonstrate that Asian ZIKV infection preferentially leads to the M2-skewed immunosuppression phenotype host immune response.

Transcriptome analysis of blood monocytes upon MR766 or H/PF/2013 ZIKV infection {#S9}
--------------------------------------------------------------------------------

Since CD14^+^ monocytes were the primary target cells for ZIKV infection in blood, we isolated total monocytes from mock- and ZIKV-infected whole blood at 40 hpi, followed by multiplexed gene expression analysis using NanoString nCounter platform that targets \~600 myeloid cell-related genes ([Supplementary dataset 1](#SD2){ref-type="supplementary-material"}). Analysis of infected non-pregnant women's monocytes revealed the specific induction of a larger pool of myeloid cell-related genes upon infection with MR766 (75 genes) than with H/PF/2013 (42 genes) ([Fig. 6a](#F6){ref-type="fig"} and [Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). In addition, MR766 infection led to a higher induction of IFN-signaling pathway genes compared to H/PF/2013 infection ([Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}). Most host genes induced by MR766 infection were M1-skewed inflammation-related \[*CXCL10, IL-12B*, and prostaglandin-endoperoxide synthase 2 (*PTGS2*)\] and pro-inflammatory genes \[complement factor 3 (*C3)*, resistin-like beta (*RETNLB*), ribonuclease A family member 3 (*RNASE3*) and *IL-27*\], whereas H/PF/2013 infection-induced host genes were M2-skewed immunosuppression related \[*IL-10, IL-4* and platelet-derived growth factor subunit B (*PDGFB*)\] ([Fig. 6b](#F6){ref-type="fig"}). In addition, H/PF/2013 infection induced host genes for fatty acid oxidation \[lipoprotein lipase (*LPL*)\] and collagen deposition \[*ADAMTS14*, discoidin domain-containing receptor 2 (*DDR2*) and collagen alpha-1(X) chain (*COL10A1*)\] that are crucial for M2 macrophage function ([Fig. 6b](#F6){ref-type="fig"}). Interestingly, unlike monocytes from non-pregnant women which showed induction of a larger pool of myeloid cell-related genes following MR766 infection rather than H/PF/2013 infection ([Fig. 6a](#F6){ref-type="fig"} and [Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}), monocytes from pregnant women were more reactive to H/PF/2013 infection than MR766 infection ([Fig. 6c](#F6){ref-type="fig"}). Consistent with a clinical study showing that Asian ZIKV infection during the first and second trimester led to a significantly higher frequency of fetal anomalies^[@R25],[@R26]^, H/PF/2013 infection induced expression of a higher number of host genes in monocytes from women in their first and second trimesters of pregnancy than women in their third trimester of gestation or non-pregnant ([Fig. 6c](#F6){ref-type="fig"}). Interestingly, we also observed that two host pregnancy complication-associated genes ADAMTS9 and fibronectin 1 (FN1)^[@R27]--[@R31]^ were induced in PBMCs and monocytes of women in their first and second trimesters of pregnancy following Asian ZIKV infection ([Fig. 6c,d](#F6){ref-type="fig"}). Indeed, serum FN1 exhibited significantly elevated levels in ZIKV^+^ pregnant patients in any trimester of pregnancy as well as in ZIKV^+^-viremic or -viruric pregnant women ([Fig. 6e](#F6){ref-type="fig"}). In summary, we demonstrate that infections with different lineages of ZIKV lead to different expression profiles of host immune genes and that this effect is dependent on pregnancy stage, especially during the first and second trimesters of gestation. Furthermore, our results show that Asian ZIKV infection induces the aberrant expression of host pregnancy complication-associated genes *FN1* and *ADAMTS9*, which may contribute to adverse pregnancy outcomes.

Discussion {#S10}
==========

The recent re-emergence of ZIKV infection and its ominous association with congenital anomalies during pregnancy has captivated global attention^[@R25],[@R26],[@R32],[@R33]^. Despite large clinical cohort studies of ZIKV-infected pregnant women, the dynamics of viral replication and blood immunity of ZIKV remains elusive. ZIKV viremia in infected patients typically resolves in the first week of infection, as early as 72 hpi^[@R34]^. Due to the short viremic phase and mild clinical symptoms, identifying acute ZIKV patients and obtaining their blood specimens has been a challenging task. So far, ZIKV replication dynamics has been largely studied using *in vitro* cell lines or *in vivo* IFN-α/β receptor knockout (IFNAR^−/−^) mouse model^[@R35]^, however, none of these systems may fully recapitulate human blood infection. Specifically, the host target cells of ZIKV infection and the acute immune responses of blood following an infectious mosquito bite have not been well-studied. Hence, to overcome this issue, we utilized an *in vitro* human whole blood infection approach that mimics the natural infection setting of ZIKV viremia in humans. This approach has been shown to be an effective platform for dissecting acute host immunity mediated against viruses, such as Chikungunya virus and vaccinia virus^[@R36],[@R37]^. Although the whole blood infection approach has been a useful *in vitro* model for studying blood immunity, the caveat of this approach is the inability to access the infectivity of non-PBMCs population, such as short-lived granulocytes. Here, we identified CD14^+^ monocytes as the primary target cells of acute ZIKV infection. Furthermore, higher viral burdens were detected in CD14^+^ monocytes infected with African lineage ZIKV strain than in those infected with the Asian lineage ZIKV strain. The mechanisms responsible for this difference of replication kinetics between African lineage ZIKV *vs.* Asian lineage ZIKV in human CD14^+^ monocytes are under investigation.

Blood monocytes have been shown to be a favorable cellular target for several other viruses, such as influenza A virus, vesicular stomatitis virus and vaccinia virus, while viral infections rapidly trigger differentiation of monocytes into DCs^[@R38]^. Recently, Asian ZIKV infection of non-human primates was shown to trigger a peak of CD16^+^ monocytes activation at 2 days post infection^[@R39]^. Here we showed that in human blood, both lineages of ZIKV strains triggered the specific expansion of CD14^lo^ CD16^+^ non-classical monocytes, but not the CD14^hi^ CD16^+^ intermediate monocyte population. While African lineage ZIKV promoted a modest expansion of non-classical monocytes, it targeted intermediate monocytes as the preferred monocyte subset that specifically induced CXCL10-associated M1-skewed inflammatory responses. Surprisingly, despite a lower viral burden and infectivity, Asian lineage ZIKV infection led to the large expansion of non-classical monocytes, the suppression of type I IFN-signaling pathway and the promotion of IL-10-associated M2-skewed immunosuppressive phenotype. Similar to other mosquito-borne RNA viruses, this immunophenotype was likely due to a bystander effect. Previous studies have demonstrated that the infection of a small subset of blood cells with chikungunya virus is sufficient to trigger the robust activation of monocytes, leading to a cytokine storm^[@R37],[@R40]^. In addition, previous studies of HIV-1 infection-elicited immunodeficiency have suggested the possible pathogenic involvement of CD16^+^ monocytes through differentiation into M2 macrophages^[@R41]^. An expanded population of CD16^+^ monocytes have been specifically observed in HIV patients who experienced high viremia, while patients who maintained undetectable viremia showed reduced CD14^lo^ CD16^+^ non-classical monocyte populations^[@R42],[@R43]^. Just as the poor prognosis of HIV infection is closely associated with uncontrolled viremia, the high viremia of ZIKV has also been associated with lethality in patients with pre-existing medical conditions^[@R44]^. The unexpected resemblance of monocyte expansion and responses elicited by Asian ZIKV or HIV infection suggests that Asian ZIKV may trigger a certain degree of immunosuppression, whereby an inadvertent exacerbated disease outcome may occur in patients with underlying immune-altering conditions.

Pregnancy is a sophisticated biological process that relies on maternal-initiated immunosuppression towards the growing fetus particularly during early to mid-stages of pregnancy to ensure a healthy birth. Recent clinical study on 131 pregnant ZIKV^+^ patients has demonstrated that maternal viral burden or disease severity is not underlying risk factors for the development of fetal abnormalities^[@R45]^. However, prolonged ZIKV viremia during the first trimester of pregnancy has been associated with fetal abnormalities^[@R46],[@R47]^, suggesting that the pregnancy stage of ZIKV infection may be risk determinant for ZIKV-associated birth defects. Interestingly, infection of blood obtained from pregnant women, particularly those who were in their first trimester of pregnancy, exhibited enhanced viremia following African or Asian ZIKV infection. These suggest that a higher viral burden would require longer time to be cleared from the peripheral system, leading to prolong viremic phase. Since monocytes from pregnant women did not show an obvious increase in infectivity, slightly reduced IFN-β level during pregnancy may contribute to an enhanced viral burden. Indeed, ZIKV has been widely known to be highly sensitive to type I IFN signaling pathways^[@R48],[@R49]^. In addition, it has been shown that pregnancy alone can induce the expansion of intermediate/non-classical monocytes with a declined classical subset^[@R50]^. Intriguingly, Asian ZIKV infection triggered pronounced changes in blood immunity specifically during the first and second trimester of pregnancy, which further promoted the dramatic expansion of CD14^lo^ CD16^+^ non-classical monocytes and the apparent production of the IL-10 cytokine. The early to mid-stages of healthy pregnancies occur in a Th2-bias environment where IL-10 expression modestly increases to elicit a subtle immunosuppressive effect. However, the abundant production of IL-10 in response to Asian ZIKV is likely to do more harm than good in regards to the pregnancy outcome, as many viruses have been shown to exploit the elevated levels of IL-10 as a means to promote viral persistency and to dampen host defenses^[@R51]--[@R53]^. Increased IL-10 levels have been detected in the amniotic fluid of pregnant ZIKV patients who had microcephalic fetuses or neonates^[@R54]^. The highest frequencies of reported ZIKV-induced fetal defects were observed when ZIKV infection occurred in the first and second trimesters of pregnancy^[@R25],[@R26]^. Hence, we hypothesize that the expression of certain genes potentially detrimental to pregnancy may be induced in the first and second trimester specifically following Asian ZIKV infection. Indeed, the comparison of host genes uniquely induced by Asian ZIKV in monocytes from women in the first and second trimesters revealed high expressions of two pregnancy-detrimental genes -- *ADAMTS9* and *FN1*. ADAMTS9 plays a crucial role in vascular remodeling during pregnancy^[@R27]^. Elevated *ADAMTS9* expression has been implicated in placental abnormalities, leading to pre-term, small birth weight and/or labor arrest disorders^[@R28],[@R29]^. Increased levels of *FN1* are found in pregnant women suffering from pregnancy complications such as pre-eclampsia and fetal growth restriction^[@R30],[@R31]^. Surprisingly, we also found that ZIKV^+^-viremic or -viruric pregnant women showed elevated serum FN1 levels throughout all trimesters of pregnancy ([Fig. 6e](#F6){ref-type="fig"}). Hence, our findings suggest the potential pathogenic roles of pregnancy-detrimental genes such as *ADAMTS9* and *FN1* contributing to ZIKV-associated congenital defects.

Currently, all epidemic strains of disease-associated ZIKV belong to the Asian lineage^[@R55]^. Our data demonstrate a stark contrast in blood immunity elicited following infection with different lineage ZIKV strains, especially during pregnancy. Specifically, Asian lineage ZIKV infection led to the profound expansion of non-classical monocytes, an M2-skewed immunosuppressive phenotype of infected monocytes, and the aberrant expression of pregnancy detrimental genes. While this study provides a better understanding of how Asian ZIKV manipulates the host immunity which ultimately leads to adverse pregnancy outcomes, it does not negate the role of inflammatory properties induced by African ZIKV infection. The robust induction of CXCL10-associated M1 inflammatory responses during African ZIKV infection resembles many acute inflammatory conditions such as those seen in infections with West Nile virus^[@R56]^ and Japanese encephalitis virus^[@R57]^. In a healthy pregnancy, M1 polarization occurs in the third trimester prior to full term birth^[@R11]^. Overt inflammation during early to mid-stages of pregnancy can lead to preterm birth^[@R58]^. Thus, this suggests the possibility of complicated pregnancy outcomes regardless of African or Asian ZIKV infection. In summary, our study identified the primary cellular target of ZIKV in the human blood and characterized the heightened sensitivity of maternal monocytes to this virus during pregnancy. This potentially brings new directions for additional immunological studies of ZIKV infection-induced host immunity during pregnancy, which should be instrumental for developing future therapeutic interventions for improved pregnancy and fetal outcomes.

Methods {#S11}
=======

Human subjects and blood collection {#S12}
-----------------------------------

Peripheral blood specimens were obtained from healthy donors aged 18 to 39 years old and stored temporarily at 37 °C in lithium heparin-containing tube (BD) prior to infection. Blood specimens used in [Figure 1](#F1){ref-type="fig"}--[4](#F4){ref-type="fig"} were obtained from male and female subjects of equal distribution. Pregnant subjects were recruited at Los Angeles County (LAC) + University of Southern California (USC) Medical Center, with the following exclusion criteria: (i) vaccination within last 14 days, (ii) suspected/recent illness within last 14 days, (iii) steroid administration during pregnancy, (iv) immunodeficiency/immunocompromised conditions, (v) autoimmune disorders, and (vi) suspected fetal anomalies. Pregnancy was categorized into three trimesters based on the following: first trimester \<12 weeks, second trimester 12--28 weeks and third trimester \>28 weeks. Blood serum specimens from 30 symptomatic ZIKV^+^ pregnant women, 10 from each trimester, were collected from pregnant women who were admitted to the acute febrile illness clinic at the Oswaldo Cruz Foundation exhibiting rash that had developed within the previous 5 days. All patients were confirmed to be ZIKV-positive following the performance of reverse transcription-PCR (qRT-PCR) assay in blood or urine which utilized specific probe and primers for ZIKV detection^[@R59]^. Serum aliquots from these patients were stored at −80 °C until the performance of the present experiments. Written and oral informed consents were obtained prior to the collection of whole blood, sera and urine specimens from healthy individuals and ZIKV^+^ pregnant patients, and study protocols were approved by institutional review boards of the USC Institutional Review Board (IRB), Fundação Oswaldo Cruz (Fiocruz) and the University of California, Los Angeles (UCLA).

Viruses {#S13}
-------

African ZIKV strains MR766 (Uganda, 1947) and IbH30656 (Nigeria, 1968), as well as Asian ZIKV strain PRVABC59 (Puerto Rico, 2015) virus stocks were purchased from ATCC. Asian ZIKV strain H/PF/2013 (French Polynesia, 2013) was kindly provided by Dr. Michael Diamond (Washington University School of Medicine). All ZIKV virus stocks were propagated in Vero cell line (ATCC CCL-81, ATCC) and supernatant was harvested at 3--5 dpi. The viral titers were determined by plaque assays on Vero cells. Vero cells were authenticated by morphology check and growth curve analysis, and validated to be mycoplasma-free using Hoechst staining.

*In vitro* whole blood infection and PBMCs/plasma isolation {#S14}
-----------------------------------------------------------

Anti-coagulated whole blood specimens were diluted in equal volume of serum-free RPMI (Gibco) prior to ZIKV infection at MOI 0.1 or 1. PBMCs count per ml of whole blood per donor was counted prior to infection with the appropriate amount of virus. Blood specimens were incubated at 37 °C with intermittent shaking for 24 or 40 hpi. Isolation of PBMCs or plasma were performed by density gradient centrifugation using SepMate (STEMCELL) and lymphocyte separation medium (Corning). Plasma specimens were collected and stored at −80°C prior to use. PBMCs were further processed for RNA extraction, FACS staining or cell sorting. In this study, total cell population rather than sorted ZIKV^+^ cells were used for all downstream analyses, and were generally termed as "ZIKV/MR766/H/PF2103-infected" specimens.

Flow cytometry and cell sorting {#S15}
-------------------------------

Surface staining of PBMCs were performed with the following antibodies: CD45-BV421 (clone HI30, Biolegend), CD14-AF488 (clone M5E2, Biolegend), CD56-PerCP-Cy5.5 (clone 5.1H11, Biolegend), CD3-AF647 (clone HIT3a, Biolegend) and CD19-PerCP (clone HIB19, Biolegend). PBMCs specimens were either sorted based on surface markers expression using BD LSR III (BD) or proceed on to intracellular ZIKV staining for detection of ZIKV-infected cells. Indirect intracellular ZIKV staining was performed using pan flavivirus antibody (clone D1-4G2-4-15, EMD Millipore), followed by fluorescence-conjugated secondary antibody. For profiling of monocyte subsets, separate surface staining for CD45-BV421, CD14-AF488 and CD16-AF647 (clone 3G8, Biolegend) were performed on PBMCs. All fluorescence-conjugated antibodies were purchased from Biolegend. FACS acquisitions were performed on BD FACSCanto II (BD), using BD FACSDIVA software. All FACS data was analyzed using FlowJo software.

RNA extraction, viral load and gene expression analyses {#S16}
-------------------------------------------------------

Total RNA extractions were performed using RNeasy mini/micro Kit (Qiagen) according to manufacturer's instructions. RNA concentration was determined by NanoDrop 1000 spectrophotometer (Thermo Scientific). Extracted total RNA was reverse-transcribed using iScript cDNA synthesis kit (BIO-RAD) according to the manufacturer's instructions. For viral load detection, specific ZIKV NS1 primers and probe targeting conserved NS1 region across all 4 ZIKV strains (MR766, IbH30656, H/PF/2013 and PRVABC59) were designed. Standard curve (10^1^ to 10^8^ NS1 copies/μl) was generated using serial dilutions of plasmid expressing MR766 NS1 protein. Viral load and gene expression qRT-PCR were performed with 10 ng of cDNA/well using SsoAdvanced Universal Probe Supermix (BIO-RAD) or iQ SYBR Green Supermix (BIO-RAD), respectively. All qRT-PCR reactions were performed using BIO-RAD CFX96 Touch Real-Time PCR Detection System on 96-well plates. Amount of viral load in specimens were interpolated from standard curve using Prism Graphpad software. All viral load qRT-PCR performed in this study included mock controls in which no CT values could be detected. Gene expression fold change was calculated with the ΔΔCt method using Microsoft Excel. Briefly, ΔΔCt = ΔCt(ZIKV-infected)--ΔCt(mock control) with ΔCt = Ct(gene-of-interest)---Ct(housekeeping gene-GAPDH). The fold change for each gene is calculated as 2^−ΔΔCt^. All primers and probe sequences used in this study is available upon request.

Pan monocyte isolation and human myeloid gene expression analysis {#S17}
-----------------------------------------------------------------

Total monocyte population was isolated from PBMCs using Pan Monocyte Isolation Kit (Miltenyi Biotec), according to manufacturer's instructions. nCounter assay using Human Myeloid Panel (650 genes) (NanoString Technologies) was performed using 1.5 μl of monocyte lysates in RLT lysis buffer (Qiagen) of \~6500 cells/μl, according to manufacturer's instructions. Gene expression analyses were performed using NanoString nSolver software. Background was eliminated by subtracting mean nCounter counts of negative controls supplied in the kit, across counts of all specimens. Gene expressions were expressed as fold change relative to controls (mock-infected specimens). Genes with fold change \> 1.5 is considered to be induced. The NanoString gene analysis data were deposited in the NCBI GEO database under the accession code GSE101718.

Multiplex immunoassay and ELISA {#S18}
-------------------------------

Serum levels of human IL-12 p40, IL-10, sCD163 and YKL-40 were detected using Bio-plex multiplex immunoassay (BIO-RAD). Human CXCL10 and IL-10 ELISA assays (Biolegend) were performed on plasma specimens according to manufacturer's instructions. Human FN1 ELISA assay (LSBio) was performed on serum specimens according to manufacturer's instructions.

Statistical analyses {#S19}
--------------------

All statistical analyses were performed using GraphPad Prism 5.0 software. For analyses between 2 groups, Mann-Whitney *U* test were used. For comparisons among more than 2 groups, either one-way or two-way ANOVA, Bonferroni post-test was used.

Data availability {#S20}
-----------------

The data supporting the findings of this study are available in the paper and [Supplementary Information](#SD1){ref-type="supplementary-material"}. All primers and probe sequences used in this study are available upon request. The NanoString gene analysis data were deposited in the NCBI GEO database (<https://www.ncbi.nlm.nih.gov/geo>), under the accession code GSE101718.

Supplementary Material {#S21}
======================

We thank Drs. Michael Diamond and Cécile Baronti for providing ZIKV H/PF/2013 strain, and all healthy volunteers for blood donation. This work was partly supported by CA200422, CA180779, DE023926, AI073099, AI116585, Hastings Foundation and Fletcher Jones Foundation (J.U.J.), MH106806 (A.B.), and 2T90DE021982-06 (J.W.B.), AI28697 and 1R21AI129534-01 from the National Institute of Allergy and Infectious Diseases/National Institutes of Health (K.N.S.), and CAPES/88887.116627/2016-01 from Departamento de Ciência e Tecnologia (DECIT) do Ministério da Saúde do Brasil and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (P.B.).

**Author Contributions**

S.-S.F. performed and analyzed all experiments, prepared the figures and wrote the first draft of the manuscript. W.C., Y.C., J.W.B., L.C.C., Y.C., J.S.Y., J.G., G.C., A.B., K.N.S. and P.B. collaborated for the experimental design and interpretation. S.-S.F. and J.U.J. jointly conceived the experimental design, interpreted the results and wrote subsequent drafts of the manuscript.

**Competing financial interests**

None

![ZIKV infects CD14^+^ monocytes and drives monocyte subset shift to CD16^+^ non-classical subset during whole blood infection\
Whole blood derived from healthy donors (*n* = 8) were infected with African ZIKV (MR766) or Asian ZIKV (H/PF/2013) at MOI 1 for 24 h. PBMCs were isolated at 24 hpi for fluorescence-activated cell sorting (FACS) or RNA extraction. **a**, Schematic representation of experimental set-up. **b**, Viral burden of total PBMCs or **c**, sorted immune subsets (CD45^+^ CD14^+^ monocytes, CD45^+^ CD56^+^ NK cells, CD45^+^ CD3^+^ T cells and CD45^+^ CD19^+^ B cells) were detected using viral load qRT-PCR with the specific probes and primers against the ZIKV NS1 RNA. **d**, Intracellular ZIKV Env antigen in various blood subsets were determined using FACS. **e**, Flow cytometry profiling of classical (CD14^+^ CD16^−^), intermediate (CD14^hi^ CD16^+^) and non-classical (CD14^lo^ CD16^+^) monocyte subsets of mock- and ZIKV-infected PBMCs were expressed as percentage change relative to mock controls, or presented as no. of cells per subset within a gated CD45^hi^ SSC^hi^ myeloid population (10^5^ cells). Data (mean ± SEM) were presented in box plot showing upper (75%) and lower (25%) quartiles, with horizontal line as median and whiskers as maximum and minimum values observed. \* *P* \< 0.05, \*\*\* *P* \< 0.0001, Mann-Whitney *U* test in (**b**) or two-way ANOVA, Bonferroni post-test in (**c**--**e**).](nihms896452f1){#F1}

![Different lineages of ZIKV infection of whole blood elicit differential immunomodulatory responses\
Mock- or ZIKV-infected PBMCs and plasma were isolated from whole blood of equal number of male and female donors (*n* = 8) at 24 hpi. **a**, Representative heat map of 44 immune mediator profiles in PBMCs. **b**, Plasma IFN-β level was determined by ELISA. Gene expression profiles of **c**, type I IFN signaling genes (*STAT1/2*, *OAS1/3* and *viperin*), **d**, M1-skewed pro-inflammatory genes (*CXCL10*, *IL-23A*, *CD64*, *CD80*, *IL-18*, *IDO*, *SOCS1* and *CCR7*), and **e**, M2-skewed immunosuppression genes (*IL-10*, *Arg-1*, *CD200R*, *CD163*, *CD23*, *CCL22* and *VEGF*) were normalized to *GAPDH* and expressed as fold changes relative to mock controls. **f**, CXCL10 and IL-10 protein expressions within isolated plasma specimens (*n* = 8) were determined using ELISA. **g**, *CXCL10* and *IL-10* mRNA expressions within sorted immune subsets from isolated PBMCs (*n* = 4), using qRT-PCR. Data (mean ± SEM) were presented in box plot showing upper (75%) and lower (25%) quartiles, with horizontal line as median and whiskers as maximum and minimum values observed. \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.0001, Mann-Whitney *U* test in (**c**--**e**), one-way ANOVA for (b and f) or two-way ANOVA in (**g**), Bonferroni post-test.](nihms896452f2){#F2}

![Asian ZIKV preferentially targets non-classical monocytes, driving specific IL-10 expression\
PBMCs were isolated from whole blood derived from healthy donors (*n* = 6 -- 11), followed by African ZIKV (MR766) or Asian ZIKV (H/PF/2013) infections at MOI 1 for 2, 5 or 8 dpi. **a**, Schematic representation of experimental set-up. **b**, Viral burden of total monocytes (*n* = 6) during longitudinal infections detected using viral load qRT-PCR with the specific probes and primers against the ZIKV NS1 RNA. **c**, Flow cytometry profiling of classical (CD14^+^ CD16^−^), intermediate (CD14^hi^ CD16^+^) and non-classical (CD14^lo^ CD16^+^) monocyte subsets of mock- and ZIKV-infected monocytes were expressed as percentage change relative to mock controls, or presented as no. of cells per subset within a gated CD45^hi^ SSC^hi^ myeloid population (10^5^ cells). **d**, At 2 dpi, total monocytes (*n* = 11) were harvested to determine infectivity of total monocytes or **e**, gated monocyte subsets using intracellular ZIKV Env antigen staining by FACS. **f**, Viral burden were determined within sorted monocyte subsets using viral load qRT-PCR. **g**, CXCL10 and **h**, *IL-10* mRNA expressions within sorted monocyte subsets were determined using qRT-PCR. **i**, Cell viability of total monocytes were determined using live/dead staining by FACS analysis. Data (mean ± SEM) were presented in box plot showing upper (75%) and lower (25%) quartiles, with horizontal line as median and whiskers as maximum and minimum values observed. \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.0001, two-way ANOVA in (**b**, **d**--**e** and **g**--**i**) or one-way ANOVA in (**c** and **f**), Bonferroni post-test.](nihms896452f3){#F3}

![Pregnancy is associated with enhanced ZIKV infection and profound monocyte subset shift\
Whole blood was obtained from healthy non-pregnant (*n* = 10) and pregnant women (*n* = 5 per trimester) who were in the first (1^st^), second (2^nd^) or third (3^rd^) trimester of pregnancy. ZIKV infections were performed at MOI 1 and PBMCs were isolated at 40 hpi. Viral burdens within total PBMCs of **a**, non-pregnant and pregnant subjects or **b**, non-pregnant and each trimester were detected using viral load qRT-PCR with the specific probes and primers against the ZIKV NS1 RNA. **c**, Intracellular ZIKV E antigen in various blood subsets (CD45^+^ CD14^+^ monocytes, CD45^+^ CD56^+^ NK cells, CD45^+^ CD3^+^ T cells and CD45^+^ CD19^+^ B cells) were determined using FACS. **d**, Flow cytometry profiling of classical (CD14^+^ CD16^−^), intermediate (CD14^hi^ CD16^+^) and non-classical (CD14^lo^ CD16^+^) monocyte subsets present within mock- and ZIKV-infected PBMCs were presented as no. of cells per subset within a gated CD45^hi^ SSC^hi^ myeloid population (10^5^ cells), or **e**, expressed as percentage change relative to mock controls. Data (mean ± SEM) were presented in box plot showing upper (75%) and lower (25%) quartiles, with horizontal line as median and whiskers as maximum and minimum values observed. \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.0001, two-way ANOVA, Bonferroni post-test in (**a**,**c**--**e**) or one-way ANOVA, Bonferroni post-test in (**b**).](nihms896452f4){#F4}

![Pregnancy exacerbates Asian ZIKV-induced M2-skewed immunosuppression\
Mock- or ZIKV-infected PBMCs (MOI 1) and plasma were isolated from whole blood of non-pregnant (*n* = 10) and pregnant women (*n* = 5 per trimester) at 40 hpi. Protein expressions of **a**, IFN-β, **c**, CXCL10 and **e**, IL-10 within plasma isolated from mock- or ZIKV-infected whole blood were determined using ELISA. Gene expression profiles of **b**, IFN-related genes (*STAT1/2*, *OAS1/3* and *viperin*), **d**, M1 macrophage-related genes (*CXCL10*, *IDO*, *CD80*, *CCR7* and *SOCS1*), and **f**, M2 macrophage-related genes (*IL-10*, *Arg-1*, *CD200R*, *CCL22* and *YKL-40*) were normalized to GAPDH and expressed as fold change relative to mock controls. **g--j**, Multiplex cytokine analyses of IL-10 (g), sCD163 (h) YKL-40 (i), and IL-12 p40 (j) of serum specimens derived from healthy pregnant women (*n* = 4--5/trimester) and ZIKV^+^ pregnant women (*n* = 10/trimester). Data (mean ± SEM) were presented in box plot showing upper (75%) and lower (25%) quartiles, with horizontal line as median and whiskers as maximum and minimum values observed. \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.0001, two-way ANOVA, Bonferroni post-test in (**a**, **c** and **e** -- right panel), Mann-Whitney *U* test in (**a**, **c**, **e** -- left panel, **b**, **d, f and g--j** -- first 2 panel on the left) and one-way ANOVA, Bonferroni post-test in (**g--j** -- right panel).](nihms896452f5){#F5}

![Transcriptome analysis of blood monocytes following African or Asian ZIKV infection\
Pan monocytes including classical (CD14^+^ CD16^−^), intermediate (CD14^hi^ CD16^+^) and non-classical (CD14^lo^ CD16^+^) monocyte subsets were isolated from mock- and ZIKV-infected (MOI 1) PBMCs harvested at 40 hpi. Whole cell lysates of \~10,000 cells/specimen were subjected to NanoString multiplex gene analysis using Human Myeloid panel consisting of \~600 genes. **a**, Venn diagram representation of the numbers of differentially induced genes between MR766 (African ZIKV) and H/PF/2013 (Asian ZIKV) of non-pregnant women specimens. **b**, Myeloid-related genes uniquely induced (fold change \> 1.5) by MR766 or H/PF/2013 were expressed as fold changes relative to mock controls and presented as heat maps. **c**, Myeloid-related genes uniquely induced by H/PF/2013 in 1^st^ and 2^nd^ trimester pregnant women were compared and presented as heat maps. *FN1* and *ADAMTS9* were highlighted to indicate expression in both trimesters. **d**, Expression of developmental genes *ADAMTS 9* and *FN1* in PBMCs (*n* = 10 for non-pregnant women; *n* = 5 per trimester of pregnant women) were normalized to *GAPDH* and expressed as fold changes relative to mock controls. **e**, ELISA analysis of FN1 in serum specimens derived from healthy pregnant women (*n* = 5/trimester) and ZIKV^+^ pregnant women (*n* = 8--9/trimester). Data (mean ± SEM) were presented in box plot showing upper (75%) and lower (25%) quartiles, with horizontal line as median and whiskers as maximum and minimum values observed. \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.0001, two-way ANOVA, Bonferroni post-test, Mann-Whitney *U* test in (**e** -- first 2 panel on the left) and one-way ANOVA, Bonferroni post-test in (**e** -- right panel).](nihms896452f6){#F6}
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